Center for Human Drug Research
Leiden, CL, 2333, Netherlands
NCT Number: NCT02264561
The purpose of this study is to determine whether caffeine improves attention.
Looking for future studies?
Notify Me40 year–60 year
All sexes
Interventional
Not applicable
Leiden, CL, 2333, Netherlands
Single centre single dose cross-over, placebo-controlled, double blind, randomized trial with two treatment conditions : caffeine and placebo
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Healthy male and female Aged 40-60 years
Active group
Other names: Caffeine
Time frame: duration 10 days from screening to last visit (V2)
Time frame: duration: 10 days from screening to last visit (V2)
Time frame: duration 10 days from screening to last visit V2
Société des Produits Nestlé (SPN)
Industry
The Effect of Caffeine on Attention
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07683208
Attention, Gross Motor Skills
Shenzhen, Guangdong, China
View Trial DetailsNCT06852534
Attention, Basic Science: Visual Attention in Healthy Participants
Santa Barbara, California, United States
View Trial DetailsNCT07408180
Attention
Uppsala, Sweden
View Trial DetailsNCT07405632
Attention, Cognitive Function and Well-Being
Warsaw, Masovian Voivodeship, Poland
View Trial Details